Articles From: ADP Regional Employment Report: All Four Major Regions Add Fewer Jobs in November Than Previous Six-Month Average to Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market


http://media.marketwire.com/attachments/201305/153616_60427_ADPlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163974&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for ADP Regional Employment Report: All Four Major Regions Add Fewer Jobs in November Than Previous Six-Month Average investment picks
First Keystone Corporation (OTCQB: FKYS), parent company of First Keystone Community Bank, declared a $0.27 per share quarterly cash dividend to shareholders of record as of December 9, 2014, payable December 31, 2014.
Sign-up for First Keystone Corporation Announces Fourth Quarter Dividend investment picks
Quimioterapia: Mitos y Realidades Aimed at Helping Spanish-Speaking Patients and Caregivers Take Control of Their Chemotherapy Journey THOUSAND OAKS, Calif.
Sign-up for Actress Adamari López And Amgen Launch Spanish-Language Chemotherapy: Myths Or Facts™ Website And Resources investment picks
GE Global Research and GE Energy Consulting, along with National Grid, the Department of Energy (DOE) National Renewable Energy Laboratory (NREL), and Clarkson University today announced a partnership on a research project to improve the reliability and resiliency of electricity delivery in northern New York.
Sign-up for GE, Utility, Government, and Academia Partner on Underground Microgrid Project to Improve Electricity Reliability in NY’s North Country investment picks
Granite Construction Incorporated (NYSE:GVA) announced that the joint-venture team comprised of Granite Construction Company and Pulice Construction, Inc. has been awarded a $109 million design/build contract by the Arizona Department of Transportation to reconstruct 19 miles of State Route 202 in Phoenix.
Sign-up for Granite on Joint Venture Team to Construct $109 Million Highway Improvement Project in Arizona investment picks
KILGORE, Texas, Dec.
Sign-up for Martin Midstream Partners L.P. Announces Upcoming Company Presentation investment picks
Global Bandwidth Infrastructure services provider Zayo Group Holdings, Inc. (NYSE:ZAYO) today announced a deal with wholesale carrier solutions provider IX Reach to provide colocation and dark fibre connecting main data centres in the New York and New Jersey markets.
Sign-up for IX Reach selects Zayo Group to Provide Dark Fibre Connectivity in New York investment picks
PROS Holdings, Inc. (NYSE: PRO) (the “Company”) today announced that it intends to offer, subject to market conditions and other factors, $125 million aggregate principal amount of convertible senior notes due 2019 (the “Convertible Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company expects to grant an option to the initial purchasers to purchase up to an additional $18.75 million aggregate principal amount of Convertible Notes.
Sign-up for PROS Holdings, Inc. Announces Private Offering of $125 Million of Convertible Senior Notes due 2019 investment picks
BEIJING, Dec.
Sign-up for Dehaier Medical Systems Attends Two Premier Sleep Conferences investment picks
Jacobs Engineering Group Inc. (NYSE:JEC) announced today the retirement of Craig L.
Sign-up for Jacobs Engineering Group Inc. Announces Retirement of President and CEO at Year-End investment picks
SÃO PAULO, December 3, 2014 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced that it is the recipient of an award from Relatório Bancario (Banking Report) for its advanced technologies and contribution to innovation in the financial services sector.
Sign-up for NICE Awarded by Relatório Bancario for Delivering Advanced Solutions to Financial Sector investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982520003&sourceType=1 http://media3.marketwire.com/logos/20140828-Lucara200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Lucara to Report Revenue and Cost Guidance on Monday December 8, 2014 With Conference Call Tuesday December 9, 2014 investment picks
Teledyne Technologies Incorporated (NYSE:TDY) today announced that Jason VanWees, Senior Vice President, Strategy and Mergers & Acquisitions, will be holding investor meetings on Thursday, December 4, in Los Angeles and Friday, December 5, in San Francisco.
Sign-up for Teledyne to Hold Investor Meetings investment picks
SAN FRANCISCO , Dec.
Sign-up for KindredBio Announces Update on AtoKin and Atopic Dermatitis Program investment picks
LRR Energy, L.P. (NYSE: LRE) (“LRR Energy”) announced today that its management will present at the 2014 Wells Fargo Annual Energy Symposium in New York on Wednesday, December 10, 2014, at 10:15 a.m. Eastern Time.
Sign-up for LRR Energy, L.P. to Present at the Wells Fargo Annual Energy Symposium investment picks
Durable Responses Observed with Patients on Study for up to Eight Months and Ongoing in Advanced Acute Myeloid Leukemia and Other Blood Cancers SAN FRANCISCO, Dec.
Sign-up for Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies investment picks
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for three students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation’s premier research competition for high school students.
Sign-up for New York High School Scientists Win Regional Siemens Competition at Carnegie Mellon University for Research on Improving Reproductive Health Through Meiosis and Aortic-Derived Mesenchymal Stem Cells investment picks
PLEASANTON, Calif., Dec.
Sign-up for Adept Technology Wins Innovation Award for Mobile Robot investment picks
93% (13/14) of evaluable CLL patients treated at dose levels ≥ 800mg of original formulation or any dose of the micronized formulation achieved a > 50% reduction in nodal size (a nodal PR) and 50% (7/14) achieved a partial response per iwCLL (Hallek 2008) criteria 100% (6/6) of CLL and iNHL patients achieving TGR-1202 drug concentrations above 4,000ng/ml responded at the first or second efficacy assessment with at least a nodal PR for CLL or PR for iNHL; Expansion cohorts now open at 800mg QD for CLL and 1200mg QD for iNHL, the dose level that appears to provide patients (3/3) with drug concentrations > 4,000ng/ml No drug related hepatic toxicity or colitis observed with 55 patients treated to date and median time on study of approximately 6 months and some patients on study for over 1.5 years TGR-1202 has been well-tolerated with no dose-related trends in adverse events observed and no MTD reached to date, dose escalation continues now at 1800mg QD SAN
Sign-up for Interim Data From Phase 1 Dose Escalation Clinical Trial of TGR-1202, the Once-Daily PI3K Delta Inhibitor, Demonstrates Significant Clinical Activity and Lack of Hepatic Toxicity in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma investment picks
NEWARK, Calif.
Sign-up for Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference investment picks
PLYMOUTH MEETING, Pa.
Sign-up for Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ADP Regional Employment Report: All Four Major Regions Add Fewer Jobs in November Than Previous Six-Month Average to Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent